Dr. Paddy Barrett

MAY 24, 2024

The DiRECT Trial used a calorie-restricted diet over 3-5 months and also withdrew diabetic and blood pressure control medications. All of these patients had a BMI >27. Type 2 diabetes is much more common in those with a BMI in the overweight or obese category but is not uncommon in those who are relatively normal weight.

Diabetes 86

Diabetes Diet BMI Exercise 86

Cardiology Update

JANUARY 24, 2024

These data offer an updated analysis of health estimates pertaining to the worldwide, regional, and national impact of cardiovascular diseases (CVD) and associated risk factors. Implications: a renewed focus on prevention, treatment, and control strategies is imperative to address the escalating burden of cardiometabolic risks.

Cardiovascular Disease 119

Cardiovascular Disease Research Blood Pressure Public Health 119

Physiologically Speaking

DECEMBER 15, 2023

The benefit of resistance training observed in observational studies is supported by controlled trials on resistance training, which demonstrate that this type of exercise reduces traditional and nontraditional CVD risk factors. Of course, these benefits can also extend to individuals with a BMI in the normal range.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Physiologically Speaking

DECEMBER 15, 2023

The benefit of resistance training observed in observational studies is supported by controlled trials on resistance training, which demonstrate that this type of exercise reduces traditional and nontraditional CVD risk factors. Of course, these benefits can also extend to individuals with a BMI in the normal range.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Cardiometabolic Health Congress

JULY 25, 2023

Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1]

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Physiologically Speaking

DECEMBER 22, 2023

Clinically, about 1/3 of adults have metabolic syndrome — a cluster of conditions including abdominal obesity, high blood pressure, high blood glucose, high triglycerides, and low HDL cholesterol. cm for the AMEX and PMEX groups, respectively, while the change in mean arterial pressure was 4.9 cm and 1.9 mmHg and 2.3

Exercise 52

Exercise Physiology Blood Pressure Cholesterol 52

Physiologically Speaking

DECEMBER 22, 2023

Clinically, about 1/3 of adults have metabolic syndrome — a cluster of conditions including abdominal obesity, high blood pressure, high blood glucose, high triglycerides, and low HDL cholesterol. cm for the AMEX and PMEX groups, respectively, while the change in mean arterial pressure was 4.9 cm and 1.9 mmHg and 2.3

Exercise 52

Exercise Physiology Blood Pressure Cholesterol 52

DAIC

APRIL 1, 2024

Getty Images milla1cf Mon, 04/01/2024 - 08:10 April 1, 2024 — Sleeping fewer than seven hours is associated with a higher risk of developing high blood pressure over time, according to a study presented at the American College of Cardiology ’s Annual Scientific Session. to 18 years).

Blood Pressure 102

Blood Pressure Hypertension Coronary Artery Disease Education 102

Cardiometabolic Health Congress

JANUARY 3, 2024

Obesity not only affects an individual’s physical appearance but also poses serious health risks. It increases the likelihood of developing chronic conditions such as heart disease, diabetes, and high blood pressure. Tirzepatide is a dual GIP/GLP-1 agonist that activates hormone receptors secreted in the intestines.

Obesity 97

Obesity Diabetes Blood Pressure BMI 97

Dr. Paddy Barrett

JANUARY 16, 2024

Low = 0 - 49 Moderate = 50 - 79 High = 80 - 100 What Happens To NCD Risk When You Get These Right? Yes, many external factors impact these factors, but ultimately, you have significant control over all of these. Let’s look at what happens to NCD risk when these risk factors are optimised.

Cancer 72

Cancer Dementia Diabetes Cardiovascular Disease 72

Dr. Smith's ECG Blog

DECEMBER 7, 2023

I quickly reviewed the patient’s records and saw that she was a 53 year old woman with a history of BMI 40, but no other identifiable risk factors for coronary artery disease. The absence of risk factors for coronary artery disease does not mean a patient is not at risk for OMI.

SCAD 108

SCAD Coronary Artery Disease Ischemia Cardiomyopathy 108

Dr. Paddy Barrett

OCTOBER 31, 2023

An elevated Lp(a) is a common genetic factor that is independently and causally related to premature coronary artery disease. But we must always remember that most genetic risk factors are probabilistic rather than deterministic in terms of risk.

Coronary Artery Disease 52

Coronary Artery Disease Heart Disease Atherosclerosis Cardiovascular Disease 52

DAIC

FEBRUARY 1, 2024

It was designed to evaluate an integrated risk tool (IRT) that combines genetic risk in the form of a polygenic risk score or PRS, with QRISK, a prediction algorithm for CVD. For people aged 45-64, genetics accounts for 40% as much risk as all the non-genetic risk factors combined in QRISK.

Cardiovascular Disease 110

Cardiovascular Disease Risk Factors Best Practices Cholesterol 110

Wellnest

JULY 19, 2023

However, recent studies have observed that people below 40 are also experiencing heart attacks due to high blood pressure, cholesterol, diabetes, smoking, obesity, a sedentary lifestyle, and social and mental stress. It’s essential for those at risk of coronary artery disease to be aware of the following symptoms.

Heart Attack 52

Heart Attack Heart attacks Blood Pressure Myocardial Infarction 52

DAIC

MARCH 8, 2024

The estimated relative risk reduction of MACE was 20% vs placebo (HR 0.80 [95% CI: 0.72, 0.90] p 1,2 The reduction of MACE with Wegovy was not impacted by age, sex, race, ethnicity, baseline BMI, or level of renal function impairment. in patients randomized to Wegovy 2.4 mg and 36.4% of patients receiving placebo. 10,11 In the U.S.,

Obesity 111

Obesity Heart Disease Heart Attack Heart attacks 111